|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1640 RHODE ISLAND AVENUE, NW |
Address2 | SUITE 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20036 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 61458-1406
|
||||||||
|
6. House ID# 353940050
|
TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Robert Raben, President |
Date | 01/21/2009 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Legislation from the 110th
HR 6228, the Ban Poisonous Additives Act (no Senate version). This bill would ban the chemical bisphenal-A from all food and beverage containers.
Continued: Legislation from the 110th
HR 6228, the Ban Poisonous Additives Act (no Senate version)
The Breast Cancer Fund supports this legislation because bisphenal-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to explore revisions to H.R. 6228 in anticipation of the introduction of similar legislation in the 111th Congress.
HR 5809, the Environmental Hormone Disruption Act (no Senate version)
This bill would authorize the director of the National Institute of Environmental Health Sciences (NIEHS) to establish a comprehensive program to better understand the impact of hormone disrupting pollutants in the environment on the health of women and children. The Breast Cancer Fund supports this legislation because of the need for more research on the links between environmental hazards and health. The Breast Cancer Fund has been meeting with staff of the principal author Congresswoman Slaughter to re-draft the bill in anticipation of the introduction of a version of the bill in the 111th Congress.
Future Legislative Proposals
The Breast Cancer Fund has met with staff from the Senate HELP Committee to discuss future legislation for a second War on Cancer. The Breast Cancer Fund has provided counsel on sections of the bill pertaining to cancer and the environment.
The Breast Cancer Fund has also met with staff from various House offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer.
Regulation and Legislative Intent
P.L. 110-314 The Consumer Product Safety Commission Improvement Act
This law has broadly reformed and modernized the Consumer Product Safety Commission. The Breast Cancer Fund lobbied in support of a Feinstein amendment, which inserts phthalates as a banned substance in the manufacture of childrens toys. We are now working with legislative conferees and their staff to insure effective regulatory implementation of the bill by the Consumer Product Safety Commission including submission of public comment and investigation of specific determinations by the CPSCs legislation counsel regarding specific sections of the law.
P.L. 110-354 -- Breast Cancer and Environmental Research Act of 2008
This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.
H.R.962 Preservation of Antibiotics for Medical Treatment Act
Sponsor: Rep Slaughter, Louise McIntosh
Title: To amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases.
H.R.6432 Animal Drug User Fee
Sponsor: Rep Pallone, Frank, Jr.
Title: To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the animal drug user fee program, and for other purposes.
H.R.6100 Kid-Safe Chemicals Act
Sponsor: Rep Solis, Hilda L.
Title: To amend the Toxic Substances Control Act to reduce the exposure of children, workers, and consumers to toxic chemical substances.
S.3040 Kid-Safe Chemicals Act
Sponsor: Sen Lautenberg, Frank R.
Title: A bill to amend the Toxic Substances Control Act to reduce the exposure of children, workers, and consumers to toxic chemical substances.
H.R.398 Healthy Places Act
Sponsor: Rep Solis, Hilda L.
Title: To require Federal agencies to support health impact assessments and take other actions to improve health and the environmental quality of communities, and for other purposes.
H.R.1103 Environmental Justice Act
Sponsor: Rep Solis, Hilda L.
Title: To codify Executive Order 12898, relating to environmental justice, to require the Administrator of the Environmental Protection Agency to fully implement the recommendations of the Inspector General of the Agency and the Comptroller General of the United States, and for other purposes.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Robert |
Raben |
|
|
|
Katherine |
Huffman |
|
|
|
Nancy |
Buermeyer |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |